Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring system for people with diabetes, announced the company plans to participate in the upcoming Canaccord Genuity Growth Conference in Boston, MA.
July 25, 2019
· 1 min read